Afya Limited

NASDAQ:AFYA

18.58 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 849.015841.185809.89804.239729.866723.479712.607709.961584.002580.575598.156566.324498.259454.387372.374394.351345.266309.41274.211272.304220.846206.713178.493144.578106.2492.42675.23561.32
Cost of Revenue 307.174324.083338.73269.504289.677288.234284.295247.607236.889216.691219.242186.73201.307180.042144.459126.492126.428112.292106.68389.25184.85687.3582.28354.36452.9948.18738.6828.195
Gross Profit 541.841517.102471.16534.735440.189435.245428.312462.354347.113363.884378.914379.594296.952274.345227.915267.859218.838197.118167.528183.053135.99119.36396.2190.21453.2544.23936.55533.125
Gross Profit Ratio 0.6380.6150.5820.6650.6030.6020.6010.6510.5940.6270.6330.670.5960.6040.6120.6790.6340.6370.6110.6720.6160.5770.5390.6240.5010.4790.4860.54
Reseach & Development Expenses 4.26504.527.0297.3215.3964.8693.9182.4774.2762.0310.6520.2030.3890.0180.0150.03200000000000
General & Administrative Expenses 0280.02711.798241.164274.876257.002249.586233.22201.532210.692207.415178.514178.216178.811135.184130.404121.375104.71890.03986.72377.04271.2659.58431.23421.76719.42114.58314.263
Selling & Marketing Expenses 00251.9640-452.600000000000000000000000
SG&A 285.122280.027263.762241.164274.876257.002249.586233.22201.532210.692207.415178.514178.216178.811135.184130.404121.375104.71890.03986.72377.04271.2659.58431.23421.76719.42114.58314.263
Other Expenses -5.5953.183-4.04800000.885-1.9147.371.5260.4484.7240.2442.815-1.091.674-1.890.870.0595.097-0.52-0.5760.2061.939-1.282-0.502-0.752
Operating Expenses 283.792283.21264.234246.009269.412245.579251.89234.105199.618218.062208.941178.962182.94179.055137.999129.314121.388102.82890.90986.78282.13970.7459.00831.4423.70618.13914.08113.511
Operating Income 258.049233.892230.814289.358170.593190.286176.643229.539147.068146.019170.242200.771114.01295.39992.844138.6495.86794.39776.896.27160.65248.62337.20258.77429.54426.122.47419.614
Operating Income Ratio 0.3040.2780.2850.360.2340.2630.2480.3230.2520.2520.2850.3550.2290.210.2490.3520.2780.3050.280.3540.2750.2350.2080.4070.2780.2820.2990.32
Total Other Income Expenses Net -102.687-97.318-65.523-70.194-77.837-79.92-87.016-92.707-65.672-58.912-58.601-52.482-52.378-32.393-66.044-16.618-25.032-10.132-6.57313.456-3.2036.109-14.151-7.069-2.3562.3230.3860.637
Income Before Tax 155.362136.574165.291219.16492.756110.36689.627136.83281.39687.107111.641148.28961.63463.00626.8122.02270.83584.26570.227109.72757.44954.73223.05151.70527.18828.42322.85820.251
Income Before Tax Ratio 0.1830.1620.2040.2730.1270.1530.1260.1930.1390.150.1870.2620.1240.1390.0720.3090.2050.2720.2560.4030.260.2650.1290.3580.2560.3080.3040.33
Income Tax Expense 1.08312.4323.09110.865-9.1312.1462.0919.0610.0656.6975.56813.34712.6335.0174.8558.6749.9794.696.3416.0574.4735.7481.7252.2290.851.4770.2671.394
Net Income 149.927119.979158.211203.39398.06193.34782.789112.12466.69475.76101.505129.6144.96953.0317.237108.0956.74874.83260.67999.81649.79746.26716.31741.53524.03324.34320.46217.512
Net Income Ratio 0.1770.1430.1950.2530.1340.1290.1160.1580.1140.130.170.2290.090.1170.0460.2740.1640.2420.2210.3670.2250.2240.0910.2870.2260.2630.2720.286
EPS 1.6501.742.261.091.040.921.250.740.841.121.420.480.570.181.160.610.80.651.090.540.540.190.470.270.280.230.2
EPS Diluted 1.6501.742.221.091.030.921.240.740.841.121.420.480.560.181.150.60.790.651.090.540.530.190.470.270.280.230.2
EBITDA 306.792315.5283.197338.601196.874263.66224.781273.093194.902194.762201.616230.841164.71125.057115.61160.707123.567113.97994.677114.18980.45465.62250.94163.98433.94226.79224.05320.898
EBITDA Ratio 0.3610.3750.350.4210.270.3640.3150.3850.3340.3350.3370.4080.3310.2750.310.4080.3580.3680.3450.4190.3640.3170.2850.4430.3190.290.320.341